Informed-money record

ROIV · Roivant Sciences Ltd.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

2

Bearish filings

154

Named actors

27

Disclosed $ (bull / bear)

$58K / $1.2B

Recent disclosures

25 of 156 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-06-30Director Fitzgerald Meghansold$349KSEC ↗
2026-06-30Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) KEITH S MANCHESTERfiled notice to sell$7.1MSEC ↗
2026-06-30Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MEGHAN FITZGERALDfiled notice to sell$347KSEC ↗
2026-06-29Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MELISSA EPPERLYfiled notice to sell$605KSEC ↗
2026-06-26Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATMEfiled notice to sell$17.0MSEC ↗
2026-06-25Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) MAYUKH SUKHATMEfiled notice to sell$17.1MSEC ↗
2026-06-24Officer (via Rockefeller Financial LLC) Venker Ericfiled notice to sell$6.6MSEC ↗
2026-05-22Officer (via Rockefeller Financial LLC) Venker Ericfiled notice to sell$6.1MSEC ↗
2026-05-20director Melissa Epperlyadopted a selling planSEC ↗
2026-04-20President & Immunovant CEO Venker Ericsold$5.9MSEC ↗
2026-04-20Officer (via Rockefeller Financial LLC) Venker Ericfiled notice to sell$5.9MSEC ↗
2026-04-16CEO Gline Matthewsold$8.4MSEC ↗
2026-04-16Officer (via Rockefeller Financial LLC) Gline Matthewfiled notice to sell$8.4MSEC ↗
2026-04-08Chief Accounting Officer Humes Jennifersold$384KSEC ↗
2026-04-08Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JENNIFER HUMESfiled notice to sell$384KSEC ↗
2026-03-30director Meghan FitzGeraldadopted a selling planSEC ↗
2026-03-26Director Fitzgerald Meghansold$1.9MSEC ↗
2026-03-26Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MEGHAN FITZGERALDfiled notice to sell$1.9MSEC ↗
2026-03-17President & Immunovant CEO Venker Ericsold$5.6MSEC ↗
2026-03-17Officer (via Rockefeller Financial LLC) Venker Ericfiled notice to sell$5.6MSEC ↗
2026-03-16Director Epperly Melissa B,sold$1.2MSEC ↗
2026-03-16Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MELISSA B EPPERLYfiled notice to sell$1.2MSEC ↗
2026-02-23President and Vant Chair Torti Franksold$16.2MSEC ↗
2026-02-20President and Vant Chair Torti Franksold$27.5MSEC ↗
2026-02-20Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) FRANK TORTIfiled notice to sell$44.0MSEC ↗

131 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals